DK0506769T3 - Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner - Google Patents

Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner

Info

Publication number
DK0506769T3
DK0506769T3 DK91901458.9T DK91901458T DK0506769T3 DK 0506769 T3 DK0506769 T3 DK 0506769T3 DK 91901458 T DK91901458 T DK 91901458T DK 0506769 T3 DK0506769 T3 DK 0506769T3
Authority
DK
Denmark
Prior art keywords
treating
pharmaceutical composition
retroviral infections
preventing retroviral
arg
Prior art date
Application number
DK91901458.9T
Other languages
English (en)
Inventor
Bruno Guy
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013102A external-priority patent/FR2668065B1/fr
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0506769T3 publication Critical patent/DK0506769T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91901458.9T 1989-12-18 1990-12-18 Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner DK0506769T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8916726 1989-12-18
FR9013102A FR2668065B1 (fr) 1990-10-23 1990-10-23 Composition pharmaceutique destinee au traitement et a la prevention des infections retrovirales.

Publications (1)

Publication Number Publication Date
DK0506769T3 true DK0506769T3 (da) 1994-11-28

Family

ID=26227737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91901458.9T DK0506769T3 (da) 1989-12-18 1990-12-18 Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner

Country Status (8)

Country Link
EP (1) EP0506769B1 (da)
JP (1) JPH05502868A (da)
AT (1) ATE109006T1 (da)
AU (2) AU6975591A (da)
CA (1) CA2071972A1 (da)
DE (1) DE69011130T2 (da)
DK (1) DK0506769T3 (da)
WO (1) WO1991008769A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015730A1 (en) * 1992-02-07 1993-08-19 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of hiv protease
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
NZ249789A (en) * 1992-03-11 1997-07-27 Narhex Ltd Hydrazine, carbazate and 1,2-diazacyclic derivatives and pharmaceutical compositions
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
PT666755E (pt) * 1992-09-09 2003-09-30 Us Gov Health & Human Serv Inibicao da infeccao pelo vih
FR2778851B1 (fr) * 1998-05-19 2002-07-26 Aetsrn Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
WO2005011649A2 (en) * 2003-05-19 2005-02-10 Vanderbilt University Methods of treating severe acute respiratory syndrome virus infections
US8232240B2 (en) 2005-02-23 2012-07-31 The Brigham And Women's Hospital, Inc. Inhibitors of enveloped virus infectivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8510058A8 (en) * 1985-01-16 1996-04-30 Inst Jozef Stefan P O Process for insulation of poultry egg's cystatine from egg-white
EP0269311A3 (en) * 1986-11-17 1990-06-06 Merck & Co. Inc. Methods of treating bone diseases by administration of a cysteine proteinase inhibitor

Also Published As

Publication number Publication date
EP0506769B1 (fr) 1994-07-27
DE69011130D1 (de) 1994-09-01
ATE109006T1 (de) 1994-08-15
EP0506769A1 (fr) 1992-10-07
AU6975591A (en) 1991-07-18
WO1991008769A1 (fr) 1991-06-27
JPH05502868A (ja) 1993-05-20
CA2071972A1 (fr) 1991-06-19
DE69011130T2 (de) 1995-03-16
AU644621B2 (en) 1993-12-16

Similar Documents

Publication Publication Date Title
ES2145913T3 (es) Inhibidores de metaloproteasas.
KR870005637A (ko) 약물 데포
PT83872A (de) Arzneimittel
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR0014465A (pt) 1,1'-bifenil-2-carbonamidas 2'-substituìdas, processos para a sua preparação,seu emprego como medicamento bem como os preparados farmacêuticos contendo as mesmas
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
DK0404283T3 (da) 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler
NO155239C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, blandede salter av essensielle eller semi-essensielle aminosyrer og nitrogenfri analoger derav.
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
MX9102580A (es) Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene.
PT101725A (pt) Processo para a preparacao de um composto de diarilo anti-aterosclerotico e de composicoes farmaceuticas que o contem
DK0506769T3 (da) Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
ES8100800A1 (es) Procedimiento para la preparacion de derivados furanonicos
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK84383A (da) Derivater af n,n-substitueret azolcarboxamid og landbrugs- og gartnerifungicide eller nematicide midler indeholdende samme, som aktiv bestanddel
DK681887A (da) Azolderivat, fremgangsmaade til fresmtilling heraf samt landburgsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
MXPA03001985A (es) Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.